ProfileGDS4718 / 219067_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 85% 84% 89% 86% 89% 89% 88% 85% 87% 87% 86% 87% 89% 91% 91% 87% 89% 90% 88% 76% 86% 88% 86% 87% 86% 88% 86% 87% 89% 88% 87% 89% 86% 82% 81% 88% 90% 86% 86% 89% 86% 88% 83% 90% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.5499485
GSM549102patient 115, normal, homogenized [OPG study]8.3100484
GSM549104patient 119, normal, homogenized [OPG study]9.048289
GSM549108patient 138, normal, homogenized [OPG study]8.5024186
GSM549119patient 077, normal, homogenized [OPG study]9.0287289
GSM549133patient 032, cancer, homogenized [OPG study]9.1822189
GSM549139patient 042, cancer, homogenized [OPG study]8.9143588
GSM549099patient 107, normal, homogenized [OPG study]8.449885
GSM549109patient 139, normal, homogenized [OPG study]8.677187
GSM549110patient 046, normal, homogenized [OPG study]8.7916287
GSM549114patient 063, normal, homogenized [OPG study]8.7394986
GSM549122patient 082, normal, homogenized [OPG study]8.7658487
GSM549134patient 033, cancer, homogenized [OPG study]9.0367789
GSM549136patient 036, cancer, homogenized [OPG study]9.3668391
GSM549140patient 044, cancer, homogenized [OPG study]9.3376691
GSM549111patient 047, normal, homogenized [OPG study]8.755387
GSM549113patient 057, normal, homogenized [OPG study]9.1695289
GSM549132patient 031, cancer, homogenized [OPG study]9.2037490
GSM549137patient 038, cancer, homogenized [OPG study]8.8929788
GSM549142patient 047, cancer, homogenized [OPG study]7.2856176
GSM549100patient 110, normal, homogenized [OPG study]8.515986
GSM549107patient 135, normal, homogenized [OPG study]8.9513988
GSM549115patient 068, normal, homogenized [OPG study]8.8015186
GSM549116patient 072, normal, homogenized [OPG study]8.7741287
GSM549120patient 078, normal, homogenized [OPG study]8.6564486
GSM549131patient 030, cancer, homogenized [OPG study]9.0088588
GSM549118patient 074, normal, homogenized [OPG study]8.6892786
GSM549129patient 027, cancer, homogenized [OPG study]8.6302487
GSM549123patient 088, normal, homogenized [OPG study]8.9997689
GSM549124patient 006, cancer, homogenized [OPG study]8.7124688
GSM549126patient 015, cancer, homogenized [OPG study]8.7230287
GSM549128patient 025, cancer, homogenized [OPG study]8.9960889
GSM549103patient 117, normal, homogenized [OPG study]8.4159986
GSM549117patient 073, normal, homogenized [OPG study]8.1637982
GSM549138patient 041, cancer, homogenized [OPG study]8.0052881
GSM549141patient 045, cancer, homogenized [OPG study]8.9991388
GSM549130patient 028, cancer, homogenized [OPG study]9.1222990
GSM549101patient 111, normal, homogenized [OPG study]8.5168486
GSM549105patient 128, normal, homogenized [OPG study]8.5484686
GSM549106patient 134, normal, homogenized [OPG study]9.1778289
GSM549112patient 048, normal, homogenized [OPG study]8.6853786
GSM549125patient 011, cancer, homogenized [OPG study]8.7821388
GSM549127patient 024, cancer, homogenized [OPG study]8.2075383
GSM549135patient 035, cancer, homogenized [OPG study]9.3297890